December 11th, 2017
jobs
homes

Menu
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Articles published by Tenpoint Therapeutics, Ltd.

News headline image
Tenpoint Therapeutics, Ltd. Appoints Stephen S. Lane, M.D., as Chief Medical Officer
From Tenpoint Therapeutics, Ltd.
Via Business Wire
News headline image
Tenpoint Therapeutics Secures $235 Million through Series B Stock Financing and Credit Facility to Accelerate Commercialization of YUVEZZI™
From Tenpoint Therapeutics, Ltd.
Via Business Wire
News headline image
Tenpoint Therapeutics Ltd. Announces FDA Approval of YUVEZZI™, the First and Only Combination Eye Drop Approved to Treat Presbyopia
From Tenpoint Therapeutics, Ltd.
Via Business Wire
News headline image
Tenpoint Therapeutics, Ltd. to Present at the 44th Annual J.P. Morgan Healthcare Conference on January 13, 2026
From Tenpoint Therapeutics, Ltd.
Via Business Wire
News headline image
Tenpoint Therapeutics Ltd. Announces Submission of a New Drug Application for BRIMOCHOL™ PF for the Treatment of Presbyopia to the MFDS in South Korea
From Tenpoint Therapeutics, Ltd.
Via Business Wire
News headline image
Tenpoint Therapeutics, Ltd. to Participate in Four Upcoming Investor Conferences
From Tenpoint Therapeutics, Ltd.
Via Business Wire
News headline image
Tenpoint Therapeutics, Ltd. to Participate in Upcoming Eye Care Conferences
From Tenpoint Therapeutics, Ltd.
Via Business Wire
News headline image
Tenpoint Therapeutics Ltd. to Participate in Upcoming Investor Conferences in August
From Tenpoint Therapeutics, Ltd.
Via Business Wire
News headline image
Tenpoint Therapeutics Ltd. to Participate in Virtual Presbyopia Panel Hosted by JonesTrading
From Tenpoint Therapeutics, Ltd.
Via Business Wire
News headline image
Tenpoint Therapeutics Ltd. Announces FDA Acceptance of New Drug Application for BRIMOCHOL™ PF for the Treatment of Presbyopia
From Tenpoint Therapeutics, Ltd.
Via Business Wire
News headline image
Tenpoint Therapeutics Ltd. Appoints Melissa Epperly as Chief Financial Officer
From Tenpoint Therapeutics, Ltd.
Via Business Wire
News headline image
Tenpoint Therapeutics Ltd. to Participate at Citi Biotech Private Access Day
From Tenpoint Therapeutics, Ltd.
Via Business Wire
News headline image
Tenpoint Therapeutics Ltd. Submits New Drug Application to U.S. FDA for BRIMOCHOL™ PF for the Treatment of Presbyopia
From Tenpoint Therapeutics, Ltd.
Via Business Wire
News headline image
Tenpoint Therapeutics Ltd. to Participate in Upcoming Investor Conferences in April
From Tenpoint Therapeutics, Ltd.
Via Business Wire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

More ways to get to us

Lethbridge Herald Facebook Facebook
Lethbridge Herald Twitter Twitter
Lethbridge Herald YouTube YouTube

About Us

Contact the Lethbridge Herald

504 - 7th Street South
Lethbridge, AB T1J 3Z7

[P] (403) 328-4411
[F] (403)328-4536

Print Advertising: (403) 328-4410
National Advertising: (403) 380-7585
Online Advertising: (403) 380-7585
Classifieds: (403) 328-4433

© 1996-2017 The Lethbridge Herald, A Division of Continental Newspapers Canada Ltd.